These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 7256575)

  • 41. [Dyslipidemia characteristics in arterial hypertension].
    Neverov IV; Baĭmatova DD
    Sov Med; 1984; (6):46-9. PubMed ID: 6379903
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hyperlipoproteinemia--problems of diagnosis and treatment. Report of the Working Group of the Polish Cardiology Society].
    Michajlik A; Ciświcka-Sznajderman M; Sznajd J; Szostak W
    Kardiol Pol; 1982; 25(12):1061-8. PubMed ID: 7169735
    [No Abstract]   [Full Text] [Related]  

  • 43. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 44. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serum lipoprotein fractions in chronic liver diseases with and without alcoholism].
    Rini GB; Averna MR; Montalto G; Di Fede G; Notarbartolo A
    Boll Soc Ital Biol Sper; 1981 Aug; 57(16):1692-7. PubMed ID: 7306412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the clinical biochemistry laboratory in the assessment of dyslipoproteinaemias.
    Ballantyne FC
    Ann Clin Biochem; 1984 May; 21 ( Pt 3)():166-75. PubMed ID: 6383181
    [No Abstract]   [Full Text] [Related]  

  • 47. [Study of the effect of migration to high-mountain regions on the blood lipoprotein system].
    Aĭtbaev KA; Madaminov IaK; Meĭmanaliev TS; Shleĭfer EA; Kim NM
    Kosm Biol Aviakosm Med; 1990; 24(6):45-6. PubMed ID: 2149868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H; Bojanovski D
    Artery; 1980; 8(2):171-8. PubMed ID: 7458684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical aspects of the problem of hyperlipoproteinemia and age].
    Reuter W
    Z Gesamte Inn Med; 1981 Mar; 36(5):141-5. PubMed ID: 7018098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid and lipoprotein tracking in 108 children over a four-year period.
    Laskarzewski P; Morrison JA; deGroot I; Kelly KA; Mellies MJ; Khoury P; Glueck CJ
    Pediatrics; 1979 Nov; 64(5):584-91. PubMed ID: 226923
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum lipoprotein deficiency in diffuse "normolipemic" plane xanthoma.
    Lindeskog GR; Gustafson A; Enerbäck L
    Arch Dermatol; 1972 Oct; 106(4):529-32. PubMed ID: 4342843
    [No Abstract]   [Full Text] [Related]  

  • 52. [Classification of hyperlipoproteinemias].
    Zabel R
    Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
    [No Abstract]   [Full Text] [Related]  

  • 53. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma lipoprotein metabolism in relation to ischaemic heart disease.
    Rogers MP
    Biochem Soc Trans; 1982 Jun; 10(3):159-61. PubMed ID: 7106365
    [No Abstract]   [Full Text] [Related]  

  • 57. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hyperlipoproteinemias, diet and drug therapy. Risk of arteriosclerosis and the lipoproteins].
    Schwandt P
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):447-8. PubMed ID: 6769012
    [No Abstract]   [Full Text] [Related]  

  • 59. [New results of studies of plasma lipoprotein metabolism and the pathogenesis of hyperlipoproteinemias].
    Szollár L
    Orv Hetil; 1984 Oct; 125(43):2599-609. PubMed ID: 6493768
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma lipid and lipoprotein concentrations in an Egyptian male sample.
    Shoukry MI; Fareed S
    Lipids; 1982 Oct; 17(10):692-5. PubMed ID: 7176826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.